MACK - Merrimack Pharmaceuticals Inc Stock Price, Fair Value and News

$15.13

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

MACK Price Action

Last 30 days

2.9%

Last 90 days

2.7%

Trailing 12 Months

21.4%

MACK RSI Chart

MACK Valuation

Market Cap

223.7M

Price/Earnings (Trailing)

1.12

Price/Sales (Trailing)

45.57

EV/EBITDA

8.91

Price/Free Cashflow

-91.55

MACK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

MACK Fundamentals

MACK Revenue

Revenue (TTM)

4.9M

MACK Earnings

Earnings (TTM)

200.5M

Earnings Growth (Yr)

74.4K%

Earnings Growth (Qtr)

84.0K%

MACK Profitability

Operating Margin

-40.77%

EBT Margin

-23.81%

Return on Equity

90.44%

Return on Assets

82.05%

Free Cashflow Yield

-1.09%

MACK Investor Care

Dividend Yield

13.22%

Dividend/Share (TTM)

Shares Dilution (1Y)

3.70%

Diluted EPS (TTM)

13.87

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2019	0	2.8M	3.8M	4.9M
2017	0	96.7M	49.2M	1.7M
2016	95.7M	92.8M	104.5M	144.3M
2015	104.6M	113.3M	101.7M	89.3M
2014	46.2M	55.5M	76.7M	102.8M
2013	52.2M	58.6M	54.2M	47.8M
2012	39.1M	44.6M	47.3M	48.9M
2011	23.8M	27.3M	30.7M	34.2M
2010	0	0	0	20.3M

Get all data in R, Python etc through our Historical Stock Data APIs

About Merrimack Pharmaceuticals Inc

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

CEO	Mr. Gary L. Crocker M.B.A., MBA
WEBSITE	merrimack.com
SECTOR	Healthcare
INDUSTRY	Biotechnology

Merrimack Pharmaceuticals Inc Frequently Asked Questions

What is the ticker symbol for Merrimack Pharmaceuticals Inc? What does MACK stand for in stocks?

MACK is the stock ticker symbol of Merrimack Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Merrimack Pharmaceuticals Inc (MACK)?

As of Tue May 28 2024, market cap of Merrimack Pharmaceuticals Inc is 223.75 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MACK stock?

You can check MACK's fair value in chart for subscribers.

Is Merrimack Pharmaceuticals Inc a good stock to buy?

The fair value guage provides a quick view whether MACK is over valued or under valued. Whether Merrimack Pharmaceuticals Inc is cheap or expensive depends on the assumptions which impact Merrimack Pharmaceuticals Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MACK.

What is Merrimack Pharmaceuticals Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 28 2024, MACK's PE ratio (Price to Earnings) is 1.12 and Price to Sales (PS) ratio is 45.57. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MACK PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Merrimack Pharmaceuticals Inc's stock?

In the past 10 years, Merrimack Pharmaceuticals Inc has provided -0.088 (multiply by 100 for percentage) rate of return.